TKL opens a new clinic; Charles River banking on biotech growth;

> CRO TKL Research has opened up a new clinic in northern New Jersey. Release

> Charles River Laboratories ($CRL) says its biotech revenue is outpacing its pharma sales, reflecting a shift in the industry. Story

Suggested Articles

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.

After three full business days in the position, an abrupt about-face has LabCorp Diagnostics’ CEO John Ratliff heading for the exit.

The initiative will see Evotec mine a kidney biobank for new renal therapy targets before the joint venture out-licenses resulting assets to Vifor.